Elenis, Evangelia http://orcid.org/0000-0002-2253-4682
Kallner, Helena Kopp
Karalexi, Maria A.
Hägg, David
Linder, Marie
Fall, Katja
Papadopoulos, Fotios C.
Skalkidou, Alkistis
Funding for this research was provided by:
Akademiska Sjukhuset (ALF 937815)
Uppsala University
Article History
Received: 8 August 2023
Accepted: 12 February 2024
First Online: 27 February 2024
Declarations
:
: The study was approved by the Swedish Ethical Review Authority (Dnr 2020/03936 with date of approval 17/08/2020). The need for written or oral informed consent was waived since all data received from the Swedish registries were pseudonymized.
: Not applicable.
: All authors have completed the ICMJE uniform disclosure form at ExternalRef removed on request from the corresponding author) and declare the following: no support from any organization for the submitted work; EE has received lecture fee from Gedeon Richter and research grant from Ferring Pharmaceuticals and serves as the medical advisor of Tilly AB; AS has received a one-time consultant fee from Biogen Inc., none of which are in any way related to this manuscript. HKK receives honorariums for lectures on contraception, fibroid care, and endometriosis from Abbvie, Actavis, Bayer, Gedeon Richter Exeltis, Nordic Pharma, Natural Cycles, Mithra, Teva, Merck, Organon, Ferring, and Consilient Health and provides expert opinions for Bayer, Evolan, Gedeon Richter, Exeltis, Merck, Teva, TV4 och Natural Cycles, Pharmiva, Dynamic Code (past), Ellen, Estercare, Pharmiva, Gedea, Gesynta, Leia, and Essity. HKK is an investigator in trials sponsored by Bayer, MSD, Mithra, Ethicon, Azanta, Gedeon Richter, Gedea, and Pharmiva. HKK teaches in courses sponsored by Organon, Bayer, and Gedeon Richter. ML and DH report participation in research projects funded by pharmaceutical companies, all regulator-mandated phase IV-studies, all with funds paid to the institution where they were employed (no personal fees) and with no relation to the work reported in this paper. The other authors declare no conflict of interest.